The FDA has now approved the first drug that can relieve depression in hours instead of weeks. In a recent article titled “FDA Approves esketamine Nasal Spray For Hard-To-Treat Depression,“ NPR stated:
A study published in the Journal of Clinical Psychiatry found that treatment with Spravato plus an oral antidepressant was associated with a rapid improvement in symptoms of depression, hopelessness, and suicidality within 24 hours of administration.
Spravato is a new FDA-approved medication that works for major depressive disorder and treatment-resistant depression. Studies show that Spravato works to reverse depressive symptoms, despite the cause. Studies also show that Spravato is working in every patient category, meaning all ages, genders, races, and duration of depression. Whether it is depression from trauma, menopause, post-partum, life events, or any other reason, Spravato is showing incredibly high rates of remission across the board for everyone. Spravato is working when nothing else has, and in ways other antidepressants never could.
Major depressive disorder and treatment-resistant depression is reversing into complete remission with Spravato nasal spray. Despite who you are or how you got to where you are, Spravato offers hope in better days.
Most insurance companies are now covering Spravato therapy; with a referral, our insurance coordinator can assist with your preauthorization. FDA guidelines state twice a week for four weeks and then weekly for weeks 5-8 and then move to once every one week or two-week dosing. The Spravato website has a nice graphic idea that might help patients who are visual learners.
1) Get Pre-Qualified
2) Get a referral
a) From us (on our website) and give it to your doctor.
b) From your doctor and give it to us.
3) Schedule your consultation
Must have transportation to and from treatment.
Continue taking an oral antidepressant.
Dissociation is not necessary for medication to provide efficacy.
Establishing with a therapist potentially improves outcomes. Treatment works much better for those who also participate in therapy.
The authorization process can take 4-8 weeks. The patient may get a letter of denial initially, but we appeal all denials and typically get them overturned.